Apellis Pharmaceuticals (APLS) Shares Issued: 2020-2025
Historic Shares Issued for Apellis Pharmaceuticals (APLS) over the last 4 years, with Sep 2025 value amounting to $797,000.
- Apellis Pharmaceuticals' Shares Issued fell 68.82% to $797,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year decrease of 85.39%. This contributed to the annual value of $14.3 million for FY2024, which is 79.91% down from last year.
- Apellis Pharmaceuticals' Shares Issued amounted to $797,000 in Q3 2025, which was down 81.75% from $4.4 million recorded in Q2 2025.
- In the past 5 years, Apellis Pharmaceuticals' Shares Issued registered a high of $380.1 million during Q1 2022, and its lowest value of $281,000 during Q1 2025.
- For the 3-year period, Apellis Pharmaceuticals' Shares Issued averaged around $8.3 million, with its median value being $4.4 million (2025).
- Its Shares Issued has fluctuated over the past 5 years, first plummeted by 99.32% in 2021, then spiked by 14,587.79% in 2022.
- Apellis Pharmaceuticals' Shares Issued (Quarterly) stood at $368.2 million in 2021, then spiked by 14,587.79% to $380.1 million in 2022, then plummeted by 95.34% to $25.5 million in 2023, then plummeted by 98.74% to $321,000 in 2024, then plummeted by 68.82% to $797,000 in 2025.
- Its Shares Issued was $797,000 in Q3 2025, compared to $4.4 million in Q2 2025 and $281,000 in Q1 2025.